NINE MONTHS RESULTS
Zydus Lifesciences Ltd.
BSE
May 02
885.45
-2.25 ( -0.25%)
Volume
11464
Prev. Close
887.70
Open Price
890.95
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
May 02
885.60
-2.65 ( -0.30%)
Volume
803068
Prev. Close
888.25
Open Price
887.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Nine Months Results
for the last 5 years.
|
ISIN No
|
INE010B01027
|
Market Cap. ( ₹ in Cr. )
|
89112.08
|
P/BV
|
4.08
|
Book Value ( ₹ )
|
216.89
|
|
BSE Code
|
532321
|
52 Week High/Low ( ₹ )
|
1324/795
|
FV/ML
|
1/1
|
P/E(X)
|
23.09
|
|
NSE Code
|
ZYDUSLIFEEQ
|
Book Closure
|
26/07/2024
|
EPS ( ₹ )
|
38.36
|
Div Yield (%)
|
0.34
|
(₹ in Crs.)
| Net Sales/Income from operations | 8956.60 | 7486.30 | 6466.60 | 5962.60 | 5675.00 |
| Other Operating Income | 340.10 | 0.00 | 0.00 | 0.00 | 96.60 |
| Total Income From Operations | 9296.70 | 7486.30 | 6466.60 | 5962.60 | 5771.60 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 2066.30 | 2264.20 | 1896.80 | 1921.80 | 1754.40 |
| Purchase of Traded Goods | 257.90 | 212.10 | 285.20 | 190.80 | 112.80 |
| Increase/Decrease in Stocks | 2.50 | -45.50 | 119.80 | -5.00 | -143.90 |
| Employees Cost | 1285.90 | 1102.40 | 968.80 | 916.00 | 852.60 |
| Depreciation | 395.90 | 373.80 | 368.70 | 355.90 | 336.10 |
| Other Expenses | 1720.50 | 1463.60 | 1514.10 | 1478.50 | 1480.80 |
| Total Expenses | 5729.00 | 5370.60 | 5153.40 | 4858.00 | 4392.80 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 3567.70 | 2115.70 | 1313.20 | 1104.60 | 1378.80 |
| Other Income | 510.80 | 723.70 | 297.20 | 125.00 | 105.80 |
| P/L Before Interest, Excpt. Items & Tax | 4078.50 | 2839.40 | 1610.40 | 1229.60 | 1484.60 |
| Interest | 308.50 | 284.50 | 193.20 | 92.90 | 50.40 |
| P/L Before Exceptional Items & Tax | 3770.00 | 2554.90 | 1417.20 | 1136.70 | 1434.20 |
| Exceptional Items | 0.00 | 0.00 | 0.00 | -319.30 | -187.50 |
| P/L Before Tax | 3770.00 | 2554.90 | 1417.20 | 817.40 | 1246.70 |
| Tax | 808.80 | 518.60 | 378.70 | 206.40 | 235.20 |
| P/L After Tax from Ordinary Activities | 2961.20 | 2036.30 | 1038.50 | 611.00 | 1011.50 |
| Net Profit/Loss For the Period | 2961.20 | 2036.30 | 1038.50 | 611.00 | 1011.50 |
| | | | | | |
| Equity Share Capital | 100.60 | 101.20 | 101.20 | 102.40 | 102.40 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 29.43 | 20.12 | 10.21 | 5.97 | 9.88 |
| Diluted EPS (Rs.) | 29.43 | 20.12 | 10.21 | 5.97 | 9.88 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 29.43 | 20.12 | 10.21 | 5.97 | 9.88 |
| Diluted EPS (Rs.) | 29.43 | 20.12 | 10.21 | 5.97 | 9.88 |
| | | | | | |
| PBITOE Margin (%) | 38.37 | 28.26 | 20.30 | 18.52 | 23.88 |
| PBTE Margin (%) | 40.55 | 34.12 | 21.91 | 19.06 | 24.84 |
| PBT Margin (%) | 40.55 | 34.12 | 21.91 | 13.70 | 21.60 |
| PAT Margin (%) | 31.85 | 27.20 | 16.05 | 10.24 | 17.52 |